Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024
SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab [Yahoo! Finance]
SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab
SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab
Hercules Capital (HTGC) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates [Yahoo! Finance]